133 related articles for article (PubMed ID: 18467331)
1. Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor.
Svensson LA; Bondensgaard K; Nørskov-Lauritsen L; Christensen L; Becker P; Andersen MD; Maltesen MJ; Rand KD; Breinholt J
J Biol Chem; 2008 Jul; 283(27):19085-94. PubMed ID: 18467331
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2.
Broutin I; Jomain JB; Tallet E; van Agthoven J; Raynal B; Hoos S; Kragelund BB; Kelly PA; Ducruix A; England P; Goffin V
J Biol Chem; 2010 Mar; 285(11):8422-33. PubMed ID: 20053995
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone.
van Agthoven J; Zhang C; Tallet E; Raynal B; Hoos S; Baron B; England P; Goffin V; Broutin I
J Mol Biol; 2010 Nov; 404(1):112-26. PubMed ID: 20875426
[TBL] [Abstract][Full Text] [Related]
4. Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL.
Jomain JB; Tallet E; Broutin I; Hoos S; van Agthoven J; Ducruix A; Kelly PA; Kragelund BB; England P; Goffin V
J Biol Chem; 2007 Nov; 282(45):33118-31. PubMed ID: 17785459
[TBL] [Abstract][Full Text] [Related]
5. Amino acids in highly conserved regions near the C-terminus of rat prolactin (PRL) play critical roles similar to those in binding of human GH to the PRL receptor.
Kato Y; Maruyama O; Chung HO; Tomizawa K; Kato T
Biochem Biophys Res Commun; 1996 May; 222(2):547-52. PubMed ID: 8670242
[TBL] [Abstract][Full Text] [Related]
6. The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor.
Dagil R; Knudsen MJ; Olsen JG; O'Shea C; Franzmann M; Goffin V; Teilum K; Breinholt J; Kragelund BB
Structure; 2012 Feb; 20(2):270-82. PubMed ID: 22325776
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of human prolactin.
Teilum K; Hoch JC; Goffin V; Kinet S; Martial JA; Kragelund BB
J Mol Biol; 2005 Aug; 351(4):810-23. PubMed ID: 16045928
[TBL] [Abstract][Full Text] [Related]
8. Characterization of lactogen receptor-binding site 1 of human prolactin.
Kinet S; Goffin V; Mainfroid V; Martial JA
J Biol Chem; 1996 Jun; 271(24):14353-60. PubMed ID: 8662911
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the ligand-binding domain of the prolactin receptor.
Rozakis-Adcock M; Kelly PA
J Biol Chem; 1991 Sep; 266(25):16472-7. PubMed ID: 1885580
[TBL] [Abstract][Full Text] [Related]
10. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
Langenheim JF; Tan D; Walker AM; Chen WY
Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
[TBL] [Abstract][Full Text] [Related]
11. Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells.
Tan D; Johnson DA; Wu W; Zeng L; Chen YH; Chen WY; Vonderhaar BK; Walker AM
Mol Endocrinol; 2005 May; 19(5):1291-303. PubMed ID: 15695371
[TBL] [Abstract][Full Text] [Related]
12. Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin.
Kang JH; Hassan SA; Zhao P; Tsai-Morris CH; Dufau ML
Biochim Biophys Acta; 2014 Jul; 1840(7):2272-80. PubMed ID: 24735798
[TBL] [Abstract][Full Text] [Related]
13. Novel reagents for human prolactin research: large-scale preparation and characterization of prolactin receptor extracellular domain, non-pegylated and pegylated prolactin and prolactin receptor antagonist.
Oclon E; Solomon G; Hayouka Z; Salame TM; Goffin V; Gertler A
Protein Eng Des Sel; 2018 Jan; 31(1):7-16. PubMed ID: 29281090
[TBL] [Abstract][Full Text] [Related]
14. Development of prolactin receptor antagonists with reduced pH-dependence of receptor binding.
Hansen MJ; Olsen JG; Bernichtein S; O'Shea C; Sigurskjold BW; Goffin V; Kragelund BB
J Mol Recognit; 2011; 24(4):533-47. PubMed ID: 20842635
[TBL] [Abstract][Full Text] [Related]
15. Discovery of the improved antagonistic prolactin variants by library screening.
Liu Y; Gong W; Breinholt J; Nørskov-Lauritsen L; Zhang J; Ma Q; Chen J; Panina S; Guo W; Li T; Zhang J; Kong M; Liu Z; Mao J; Christensen L; Hu S; Wang L
Protein Eng Des Sel; 2011 Nov; 24(11):855-60. PubMed ID: 21954059
[TBL] [Abstract][Full Text] [Related]
16. Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor.
Elkins PA; Christinger HW; Sandowski Y; Sakal E; Gertler A; de Vos AM; Kossiakoff AA
Nat Struct Biol; 2000 Sep; 7(9):808-15. PubMed ID: 10966654
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.
Kline JB; Rycyzyn MA; Clevenger CV
Mol Endocrinol; 2002 Oct; 16(10):2310-22. PubMed ID: 12351696
[TBL] [Abstract][Full Text] [Related]
18. Characterization of multiple first exons in murine prolactin receptor gene and the effect of prolactin on their expression in the choroid plexus.
Tabata H; Kobayashi M; Ikeda JH; Nakao N; Saito TR; Tanaka M
J Mol Endocrinol; 2012 Apr; 48(2):169-76. PubMed ID: 22294444
[TBL] [Abstract][Full Text] [Related]
19. Mechanism for ordered receptor binding by human prolactin.
Sivaprasad U; Canfield JM; Brooks CL
Biochemistry; 2004 Nov; 43(43):13755-65. PubMed ID: 15504038
[TBL] [Abstract][Full Text] [Related]
20. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists.
Tan D; Chen KE; Khoo T; Walker AM
Cancer Lett; 2011 Nov; 310(1):101-8. PubMed ID: 21775057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
